Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Smith Jw is active.

Publication


Featured researches published by Smith Jw.


Antimicrobial Agents and Chemotherapy | 1991

8-Aminoquinolines from Walter Reed Army Institute for Research for treatment and prophylaxis of Pneumocystis pneumonia in rat models.

M S Bartlett; Sherry F. Queener; R R Tidwell; W K Milhous; J D Berman; W Y Ellis; Smith Jw

Three 8-aminoquinolines from the Walter Reed Army Institute for Research (WRAIR), WR6026, WR238605, and WR242511, strongly inhibited Pneumocystis carinii growth in vitro at 1 microgram/ml. This activity was similar to that of primaquine. In rat therapy models, the WRAIR compounds affected Pneumocystis pneumonia at doses as low as 0.25 mg/kg (WR242511) or 0.5 mg/kg (WR6026 and WR238605). At these doses, primaquine alone was ineffective as therapy. In a rat prophylaxis model, all three WRAIR 8-aminoquinolines were extremely effective at daily doses of 0.57 mg/kg, showing activity greater than that of primaquine at this dosage and comparable to that of trimethoprim-sulfamethoxazole at 50/250 mg/kg.


Antimicrobial Agents and Chemotherapy | 1992

Antimicrotubule benzimidazoles inhibit in vitro growth of Pneumocystis carinii.

M S Bartlett; T D Edlind; M M Durkin; Margaret M. Shaw; Sherry F. Queener; Smith Jw

Nine antimicrotubule benzimidazole derivatives tested in a Pneumocystis carinii culture system with human embryonic lung fibroblast monolayers inhibited organism proliferation. The concentrations of drugs inhibitory in culture ranged from 10 to 0.1 micrograms/ml, with thiabendazole being the least effective (10 micrograms/ml) and parbendazole being the most effective (0.1 microgram/ml). The parent compound, benzimidazole, was inactive at 10 micrograms/ml. Demonstration that this group of compounds has activity against P. carinii provides a new potential target that can be exploited, the microtubules. Also, the variability in the effectiveness of the compounds provides the basis for studies of structure-activity relationships, which were initiated in this study.


Antimicrobial Agents and Chemotherapy | 1986

Activity of inosine analogs against Pneumocystis carinii in culture

Marilyn S. Bartlett; J J Marr; Sherry F. Queener; Robert S. Klein; Smith Jw

Three analogs of inosine, formycin B, allopurinol ribonucleoside, and 9-deazainosine, were tested for their ability to suppress proliferation of Pneumocystis carinii in culture with WI-38 cells. The organism was inhibited by 9-deazainosine at 10 micrograms/ml, and there was some inhibition at 1 microgram/ml. Formycin B was effective only at 40 micrograms/ml. Allopurinol ribonucleoside had little effect.


Journal of Clinical Microbiology | 1998

Update on Pneumocystis carinii f. sp.hominis Typing Based on Nucleotide Sequence Variations in Internal Transcribed Spacer Regions of rRNA Genes

Chao Hung Lee; Jannik Helweg-Larsen; Xing Tang; Shaoling Jin; Baozheng Li; Marilyn S. Bartlett; Jang Jih Lu; Bettina Lundgren; Jens D. Lundgren; Mats Olsson; Sebastian Lucas; Patricia Roux; Antonietta Cargnel; Chiara Atzori; Olga Matos; Smith Jw


Journal of Clinical Microbiology | 1997

Detection of Pneumocystis carinii DNA in air samples: Likely environmental risk to susceptible persons

Marilyn S. Bartlett; Sten H. Vermund; Robert Jacobs; Pamela J. Durant; Margaret M. Shaw; Smith Jw; Xing Tang; Jang Jih Lu; Baozheng Li; Shaoling Jin; Chao Hung Lee


Antimicrobial Agents and Chemotherapy | 1996

Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo.

Marilyn S. Bartlett; William L. Current; Michael P. Goheen; Carole J. Boylan; Chao H. Lee; Margaret M. Shaw; Sherry F. Queener; Smith Jw


Journal of Clinical Microbiology | 1998

Determination of Copy Number of rRNA Genes in Pneumocystis carinii f. sp. hominis

Xing Tang; Marilyn S. Bartlett; Smith Jw; Jang Jih Lu; Chao Hung Lee


Journal of Clinical Microbiology | 1996

Development of type-specific PCR for typing Pneumocystis carinii f. sp. hominis based on nucleotide sequence variations of internal transcribed spacer region of rRNA genes.

Bingdong Jiang; Jang Jih Lu; Baozheng Li; Xing Tang; Marilyn S. Bartlett; Smith Jw; Chao Hung Lee


Journal of Clinical Microbiology | 1987

Improved rat model for studying Pneumocystis carinii pneumonia.

Marilyn S. Bartlett; Sherry F. Queener; M A Jay; Michelle Durkin; Smith Jw


Journal of Eukaryotic Microbiology | 1991

Culture and filtration methods for obtaining Pneumocystis carinii trophozoites and cysts.

Michelle Durkin; Shaw Mm; Bartlett Ms; Smith Jw

Collaboration


Dive into the Smith Jw's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gerald Hardie

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Margaret M. Shaw

Indiana University Bloomington

View shared research outputs
Top Co-Authors

Avatar

T. H. Braid

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Xing Tang

Indiana University Bloomington

View shared research outputs
Top Co-Authors

Avatar

Jang Jih Lu

National Defense Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge